Cargando…
A case report of mesalazine-induced lung injury: A reversible drug side effect
INTRODUCTION: Mesalazine is widely used in the treatment of the acute and maintenance phase of ulcerative colitis (UC). The possibility of interstitial lung disease being induced by mesalazine in the form of eosinophilic pneumonia, organizing pneumonia, and nonspecific interstitial pneumonia has bee...
Autores principales: | Kotsiou, Ourania S., Gourgoulianis, Konstantinos I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545345/ https://www.ncbi.nlm.nih.gov/pubmed/31193970 http://dx.doi.org/10.1016/j.rmcr.2019.100865 |
Ejemplares similares
-
Lung and Gut Microbiome in COPD
por: Karakasidis, Efstathios, et al.
Publicado: (2023) -
Venous Thromboembolic Disease in Chronic Inflammatory Lung Diseases: Knowns and Unknowns
por: Keramidas, George, et al.
Publicado: (2021) -
Calprotectin in Lung Diseases
por: Kotsiou, Ourania S., et al.
Publicado: (2021) -
Impact of the financial crisis on COPD burden: Greece as a case study
por: Kotsiou, Ourania S., et al.
Publicado: (2018) -
Estimates of COVID-19 Risk Factors among Social Strata and Predictors for a Vulnerability to the Infection
por: Mouliou, Dimitra S., et al.
Publicado: (2021)